Abeona Therapeutics Provides Regulatory Update Ahead of Pivotal Phase 3 Clinical Trial for EB-101 in Recessive Dystrophic Epidermolysis Bullosa

September 23, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search